Catalysts for Sandoz Inc
291 tracked
Apr 10, 2026
approval
METHYLPREDNISOLONE โ FDA approval
MEDROL
โ
Apr 10, 2026
approval
METHYLPREDNISOLONE ACETATE โ FDA approval
METHYLPREDNISOLONE ACETATE
โ
Apr 6, 2026
approval
DAPAGLIFLOZIN โ FDA approval
DAPAGLIFLOZIN
โ
Apr 2, 2026
approval
NINTEDANIB ESYLATE โ FDA approval
Ofev
โ
Feb 12, 2026
approval
GLATOPA (GLATIRAMER ACETATE) โ FDA approval
GLATIRAMER ACETATE
โ
Feb 12, 2026
approval
ENZEEVU (AFLIBERCEPT-ABZV) โ FDA approval
aflibercept biosimilar
โ
Feb 12, 2026
approval
GLATOPA (GLATIRAMER ACETATE) โ FDA approval
GLATIRAMER ACETATE
โ
Feb 3, 2026
approval
RECLAST (ZOLEDRONIC ACID) โ FDA approval
ZOLEDRONIC ACID
โ
Feb 2, 2026
approval
TYRUKO (NATALIZUMAB-SZTN) โ FDA approval
natalizumab biosimilar
โ
Jan 30, 2026
approval
AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) โ FDA approval
UNASYN
โ
Jan 27, 2026
approval
AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) โ FDA approval
UNASYN
โ
Jan 21, 2026
approval
MICAFUNGIN SODIUM โ FDA approval
Sandoz Inc
โ
Jan 20, 2026
approval
METHYLPREDNISOLONE ACETATE โ FDA approval
METHYLPREDNISOLONE ACETATE
โ
Jan 20, 2026
approval
METHYLPREDNISOLONE ACETATE โ FDA approval
METHYLPREDNISOLONE ACETATE
โ
Jan 14, 2026
approval
SITAGLIPTIN PHOSPHATE โ FDA approval
SITAGLIPTIN PHOSPHATE
โ
Jan 5, 2026
approval
AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) โ FDA approval
amoxicillin
โ
Dec 17, 2025
approval
GABAPENTIN โ FDA approval
GABAPENTIN
โ
Dec 15, 2025
approval
PEMETREXED DISODIUM โ FDA approval
Alimta
โ
Dec 2, 2025
approval
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE) โ FDA approval
metformin hydrochloride ER
โ
Nov 24, 2025
approval
ONDANSETRON โ FDA approval
Sandoz Inc
โ
Nov 21, 2025
approval
QOLIANA (BRIMONIDINE TARTRATE) โ FDA approval
Lumify
โ
Nov 17, 2025
approval
ONDANSETRON โ FDA approval
ondansetron ODT
โ
Nov 13, 2025
approval
ONDANSETRON โ FDA approval
Sandoz Inc
โ
Nov 13, 2025
approval
ONDANSETRON โ FDA approval
Sandoz Inc
โ
Nov 6, 2025
approval
BUPROPION HYDROCHLORIDE โ FDA approval
BUPROPION HYDROCHLORIDE
โ
Oct 30, 2025
approval
TYRUKO (NATALIZUMAB-SZTN) โ FDA approval
natalizumab biosimilar
โ
Oct 29, 2025
approval
JUBBONTI (DENOSUMAB-BBDZ) โ FDA approval
JUBBONTI
โ
Oct 27, 2025
approval
DUREZOL (DIFLUPREDNATE) โ FDA approval
DIFLUPREDNATE
โ
Oct 24, 2025
approval
ANASTROZOLE โ FDA approval
ANASTROZOLE
โ
Oct 16, 2025
approval
HYRIMOZ (ADALIMUMAB-ADAZ) โ FDA approval
HYRIMOZ
โ